6869 Stock Overview
Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 3/6 |
Past Performance | 2/6 |
Financial Health | 5/6 |
Dividends | 3/6 |
Rewards
Risk Analysis
No risks detected for 6869 from our risk checks.
Sysmex Corporation Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | JP¥2,687.50 |
52 Week High | JP¥3,480.00 |
52 Week Low | JP¥2,236.00 |
Beta | 0.53 |
1 Month Change | -2.08% |
3 Month Change | 2.60% |
1 Year Change | -5.61% |
3 Year Change | -31.99% |
5 Year Change | 23.83% |
Change since IPO | 2,587.50% |
Recent News & Updates
Recent updates
Shareholder Returns
6869 | JP Medical Equipment | JP Market | |
---|---|---|---|
7D | -4.3% | -1.3% | 1.7% |
1Y | -5.6% | 24.2% | 37.6% |
Return vs Industry: 6869 underperformed the JP Medical Equipment industry which returned 24.2% over the past year.
Return vs Market: 6869 underperformed the JP Market which returned 37.6% over the past year.
Price Volatility
6869 volatility | |
---|---|
6869 Average Weekly Movement | 4.2% |
Medical Equipment Industry Average Movement | 3.8% |
Market Average Movement | 3.9% |
10% most volatile stocks in JP Market | 8.4% |
10% least volatile stocks in JP Market | 2.1% |
Stable Share Price: 6869 has not had significant price volatility in the past 3 months.
Volatility Over Time: 6869's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1968 | 9,500 | Hisashi Ietsugu | https://www.sysmex.co.jp |
Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.
Sysmex Corporation Fundamentals Summary
6869 fundamental statistics | |
---|---|
Market cap | JP¥1.68t |
Earnings (TTM) | JP¥45.06b |
Revenue (TTM) | JP¥438.28b |
37.2x
P/E Ratio3.8x
P/S RatioIs 6869 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
6869 income statement (TTM) | |
---|---|
Revenue | JP¥438.28b |
Cost of Revenue | JP¥205.29b |
Gross Profit | JP¥232.99b |
Other Expenses | JP¥187.93b |
Earnings | JP¥45.06b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 09, 2024
Earnings per share (EPS) | 72.29 |
Gross Margin | 53.16% |
Net Profit Margin | 10.28% |
Debt/Equity Ratio | 6.1% |
How did 6869 perform over the long term?
See historical performance and comparisonDividends
1.0%
Current Dividend Yield38%
Payout RatioDoes 6869 pay a reliable dividends?
See 6869 dividend history and benchmarksSysmex dividend dates | |
---|---|
Ex Dividend Date | Mar 28 2024 |
Dividend Pay Date | Jun 26 2024 |
Days until Ex dividend | 1 day |
Days until Dividend pay date | 89 days |
Does 6869 pay a reliable dividends?
See 6869 dividend history and benchmarks